Adiponectin signalling in bone homeostasis, with age and in disease
Adiponectin is the most abundant circulating adipokine and is primarily involved in glucose metabolism and insulin resistance. Within the bone, osteoblasts and osteoclasts express the adiponectin receptors, however, there are conflicting reports on the effects of adiponectin on bone formation and tu...
Gespeichert in:
Veröffentlicht in: | Bone Research 2021-01, Vol.9 (1), p.1-1, Article 1 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1 |
---|---|
container_issue | 1 |
container_start_page | 1 |
container_title | Bone Research |
container_volume | 9 |
creator | Lewis, Jonathan W. Edwards, James R. Naylor, Amy J. McGettrick, Helen M. |
description | Adiponectin is the most abundant circulating adipokine and is primarily involved in glucose metabolism and insulin resistance. Within the bone, osteoblasts and osteoclasts express the adiponectin receptors, however, there are conflicting reports on the effects of adiponectin on bone formation and turnover. Many studies have shown a pro-osteogenic role for adiponectin in in vivo murine models and in vitro: with increased osteoblast differentiation and activity, alongside lower levels of osteoclastogenesis. However, human studies often demonstrate an inverse relationship between adiponectin concentration and bone activity. Moreover, the presence of multiple isoforms of adiponectin and multiple receptor subtypes has the potential to lead to more complex signalling and functional consequences. As such, we still do not fully understand the importance of the adiponectin signalling pathway in regulating bone homeostasis and repair in health, with age and in disease. In this review, we explore our current understanding of adiponectin bioactivity in the bone; the significance of its different isoforms; and how adiponectin biology is altered in disease. Ultimately, furthering our understanding of adiponectin regulation of bone biology is key to developing pharmacological and non-pharmacological (lifestyle) interventions that target adiponectin signalling to boost bone growth and repair in healthy ageing, following injury or in disease. |
doi_str_mv | 10.1038/s41413-020-00122-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7790832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_470da4cf6d7540249dbdc633f9addf6b</doaj_id><sourcerecordid>2476052265</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-90c587d49151ab2cee4b3d68056ea5f58395a0a9bede1c76d571c6a8cb82c4df3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhiNERavSP8ABReLCgcD4M8kFqVpBW6kSl_ZsTexJ1qtsvNhZEP8eb7MtlAMnf8zjxx6_RfGGwUcGovmUJJNMVMChAmCcV_CiOOPQqkpzwV4e57IGOC0uUtrAgWpk24hXxakQ-bQEdVasLp3fhYns7Kcy-WHCcfTTUOZVl7fLddhSSDMmnz6UP_28LnGgEid3IJxPhIleFyc9jokujuN5cf_1y93qurr9dnWzurytrJIwVy1Y1dROtkwx7Lglkp1wugGlCVWvGtEqBGw7csRsrZ2qmdXY2K7hVrpenBc3i9cF3Jhd9FuMv0xAbx42QhwMxtnbkUzu26G0vXZ1vpvL1nXOaiH6Fp3rdZddnxfXbt9tyVma5ojjM-nzyuTXZgg_TF230AieBe-Pghi-7ynNZuuTpXHEicI-GS5rrTSAhIy--wfdhH3MP71QoDjXKlN8oWwMKUXqnx7DwBwiN0vkJkduHiI3B_Xbv9t4OvIYcAbEAqRcmgaKf-7-j_Y3LKG2eQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2476052265</pqid></control><display><type>article</type><title>Adiponectin signalling in bone homeostasis, with age and in disease</title><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Lewis, Jonathan W. ; Edwards, James R. ; Naylor, Amy J. ; McGettrick, Helen M.</creator><creatorcontrib>Lewis, Jonathan W. ; Edwards, James R. ; Naylor, Amy J. ; McGettrick, Helen M.</creatorcontrib><description>Adiponectin is the most abundant circulating adipokine and is primarily involved in glucose metabolism and insulin resistance. Within the bone, osteoblasts and osteoclasts express the adiponectin receptors, however, there are conflicting reports on the effects of adiponectin on bone formation and turnover. Many studies have shown a pro-osteogenic role for adiponectin in in vivo murine models and in vitro: with increased osteoblast differentiation and activity, alongside lower levels of osteoclastogenesis. However, human studies often demonstrate an inverse relationship between adiponectin concentration and bone activity. Moreover, the presence of multiple isoforms of adiponectin and multiple receptor subtypes has the potential to lead to more complex signalling and functional consequences. As such, we still do not fully understand the importance of the adiponectin signalling pathway in regulating bone homeostasis and repair in health, with age and in disease. In this review, we explore our current understanding of adiponectin bioactivity in the bone; the significance of its different isoforms; and how adiponectin biology is altered in disease. Ultimately, furthering our understanding of adiponectin regulation of bone biology is key to developing pharmacological and non-pharmacological (lifestyle) interventions that target adiponectin signalling to boost bone growth and repair in healthy ageing, following injury or in disease.</description><identifier>ISSN: 2095-4700</identifier><identifier>ISSN: 2095-6231</identifier><identifier>EISSN: 2095-6231</identifier><identifier>DOI: 10.1038/s41413-020-00122-0</identifier><identifier>PMID: 33414405</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/443/63 ; 692/163 ; 692/420 ; Adipocytes ; Age ; Aging ; Bone marrow ; Disease ; Gene expression ; Homeostasis ; Internal Medicine ; Kinases ; Medicine ; Medicine & Public Health ; Orthopedics ; Proteins ; Review ; Review Article</subject><ispartof>Bone Research, 2021-01, Vol.9 (1), p.1-1, Article 1</ispartof><rights>The Author(s) 2021</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-90c587d49151ab2cee4b3d68056ea5f58395a0a9bede1c76d571c6a8cb82c4df3</citedby><cites>FETCH-LOGICAL-c540t-90c587d49151ab2cee4b3d68056ea5f58395a0a9bede1c76d571c6a8cb82c4df3</cites><orcidid>0000-0002-5950-8840</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790832/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790832/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33414405$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lewis, Jonathan W.</creatorcontrib><creatorcontrib>Edwards, James R.</creatorcontrib><creatorcontrib>Naylor, Amy J.</creatorcontrib><creatorcontrib>McGettrick, Helen M.</creatorcontrib><title>Adiponectin signalling in bone homeostasis, with age and in disease</title><title>Bone Research</title><addtitle>Bone Res</addtitle><addtitle>Bone Res</addtitle><description>Adiponectin is the most abundant circulating adipokine and is primarily involved in glucose metabolism and insulin resistance. Within the bone, osteoblasts and osteoclasts express the adiponectin receptors, however, there are conflicting reports on the effects of adiponectin on bone formation and turnover. Many studies have shown a pro-osteogenic role for adiponectin in in vivo murine models and in vitro: with increased osteoblast differentiation and activity, alongside lower levels of osteoclastogenesis. However, human studies often demonstrate an inverse relationship between adiponectin concentration and bone activity. Moreover, the presence of multiple isoforms of adiponectin and multiple receptor subtypes has the potential to lead to more complex signalling and functional consequences. As such, we still do not fully understand the importance of the adiponectin signalling pathway in regulating bone homeostasis and repair in health, with age and in disease. In this review, we explore our current understanding of adiponectin bioactivity in the bone; the significance of its different isoforms; and how adiponectin biology is altered in disease. Ultimately, furthering our understanding of adiponectin regulation of bone biology is key to developing pharmacological and non-pharmacological (lifestyle) interventions that target adiponectin signalling to boost bone growth and repair in healthy ageing, following injury or in disease.</description><subject>631/443/63</subject><subject>692/163</subject><subject>692/420</subject><subject>Adipocytes</subject><subject>Age</subject><subject>Aging</subject><subject>Bone marrow</subject><subject>Disease</subject><subject>Gene expression</subject><subject>Homeostasis</subject><subject>Internal Medicine</subject><subject>Kinases</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Orthopedics</subject><subject>Proteins</subject><subject>Review</subject><subject>Review Article</subject><issn>2095-4700</issn><issn>2095-6231</issn><issn>2095-6231</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNp9kU1v1DAQhiNERavSP8ABReLCgcD4M8kFqVpBW6kSl_ZsTexJ1qtsvNhZEP8eb7MtlAMnf8zjxx6_RfGGwUcGovmUJJNMVMChAmCcV_CiOOPQqkpzwV4e57IGOC0uUtrAgWpk24hXxakQ-bQEdVasLp3fhYns7Kcy-WHCcfTTUOZVl7fLddhSSDMmnz6UP_28LnGgEid3IJxPhIleFyc9jokujuN5cf_1y93qurr9dnWzurytrJIwVy1Y1dROtkwx7Lglkp1wugGlCVWvGtEqBGw7csRsrZ2qmdXY2K7hVrpenBc3i9cF3Jhd9FuMv0xAbx42QhwMxtnbkUzu26G0vXZ1vpvL1nXOaiH6Fp3rdZddnxfXbt9tyVma5ojjM-nzyuTXZgg_TF230AieBe-Pghi-7ynNZuuTpXHEicI-GS5rrTSAhIy--wfdhH3MP71QoDjXKlN8oWwMKUXqnx7DwBwiN0vkJkduHiI3B_Xbv9t4OvIYcAbEAqRcmgaKf-7-j_Y3LKG2eQ</recordid><startdate>20210107</startdate><enddate>20210107</enddate><creator>Lewis, Jonathan W.</creator><creator>Edwards, James R.</creator><creator>Naylor, Amy J.</creator><creator>McGettrick, Helen M.</creator><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5950-8840</orcidid></search><sort><creationdate>20210107</creationdate><title>Adiponectin signalling in bone homeostasis, with age and in disease</title><author>Lewis, Jonathan W. ; Edwards, James R. ; Naylor, Amy J. ; McGettrick, Helen M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-90c587d49151ab2cee4b3d68056ea5f58395a0a9bede1c76d571c6a8cb82c4df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>631/443/63</topic><topic>692/163</topic><topic>692/420</topic><topic>Adipocytes</topic><topic>Age</topic><topic>Aging</topic><topic>Bone marrow</topic><topic>Disease</topic><topic>Gene expression</topic><topic>Homeostasis</topic><topic>Internal Medicine</topic><topic>Kinases</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Orthopedics</topic><topic>Proteins</topic><topic>Review</topic><topic>Review Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lewis, Jonathan W.</creatorcontrib><creatorcontrib>Edwards, James R.</creatorcontrib><creatorcontrib>Naylor, Amy J.</creatorcontrib><creatorcontrib>McGettrick, Helen M.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Bone Research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lewis, Jonathan W.</au><au>Edwards, James R.</au><au>Naylor, Amy J.</au><au>McGettrick, Helen M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adiponectin signalling in bone homeostasis, with age and in disease</atitle><jtitle>Bone Research</jtitle><stitle>Bone Res</stitle><addtitle>Bone Res</addtitle><date>2021-01-07</date><risdate>2021</risdate><volume>9</volume><issue>1</issue><spage>1</spage><epage>1</epage><pages>1-1</pages><artnum>1</artnum><issn>2095-4700</issn><issn>2095-6231</issn><eissn>2095-6231</eissn><abstract>Adiponectin is the most abundant circulating adipokine and is primarily involved in glucose metabolism and insulin resistance. Within the bone, osteoblasts and osteoclasts express the adiponectin receptors, however, there are conflicting reports on the effects of adiponectin on bone formation and turnover. Many studies have shown a pro-osteogenic role for adiponectin in in vivo murine models and in vitro: with increased osteoblast differentiation and activity, alongside lower levels of osteoclastogenesis. However, human studies often demonstrate an inverse relationship between adiponectin concentration and bone activity. Moreover, the presence of multiple isoforms of adiponectin and multiple receptor subtypes has the potential to lead to more complex signalling and functional consequences. As such, we still do not fully understand the importance of the adiponectin signalling pathway in regulating bone homeostasis and repair in health, with age and in disease. In this review, we explore our current understanding of adiponectin bioactivity in the bone; the significance of its different isoforms; and how adiponectin biology is altered in disease. Ultimately, furthering our understanding of adiponectin regulation of bone biology is key to developing pharmacological and non-pharmacological (lifestyle) interventions that target adiponectin signalling to boost bone growth and repair in healthy ageing, following injury or in disease.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>33414405</pmid><doi>10.1038/s41413-020-00122-0</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-5950-8840</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2095-4700 |
ispartof | Bone Research, 2021-01, Vol.9 (1), p.1-1, Article 1 |
issn | 2095-4700 2095-6231 2095-6231 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7790832 |
source | DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; Nature Free; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | 631/443/63 692/163 692/420 Adipocytes Age Aging Bone marrow Disease Gene expression Homeostasis Internal Medicine Kinases Medicine Medicine & Public Health Orthopedics Proteins Review Review Article |
title | Adiponectin signalling in bone homeostasis, with age and in disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A08%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adiponectin%20signalling%20in%20bone%20homeostasis,%20with%20age%20and%20in%20disease&rft.jtitle=Bone%20Research&rft.au=Lewis,%20Jonathan%20W.&rft.date=2021-01-07&rft.volume=9&rft.issue=1&rft.spage=1&rft.epage=1&rft.pages=1-1&rft.artnum=1&rft.issn=2095-4700&rft.eissn=2095-6231&rft_id=info:doi/10.1038/s41413-020-00122-0&rft_dat=%3Cproquest_doaj_%3E2476052265%3C/proquest_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2476052265&rft_id=info:pmid/33414405&rft_doaj_id=oai_doaj_org_article_470da4cf6d7540249dbdc633f9addf6b&rfr_iscdi=true |